ArticleCureus2020
Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature.
Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 47 citations in OpenAlex.
- Gut Microbiota Is Linked to Female Olfactory Preference in Giant Pandas.Animals : an open access journal from MDPI · 2026Article
- Clinical and environmental investigation of six cases of Chryseobacterium arthrosphaerae infections in a Southern Italian hospital.Scientific reports · 2025Article
- A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.AIDS research and therapy · 2025Review
- Assessing Potential Reservoir of Multidrug-Resistant Bacteria in the Oral Microbiota of Captive Burmese and Royal Pythons.Life (Basel, Switzerland) · 2025Article
- Chryseobacterium indologenes sepsis in a pediatric patient.Einstein (Sao Paulo, Brazil) · 2025Article
- Rifampin monotherapy for multidrug-resistantFrontiers in medicine · 2025Article
- Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics.Communications biology · 2024Article
- Microbial Pathogens in Aquaponics Potentially Hazardous for Human Health.Microorganisms · 2023Review
- Clinical and Microbiological Characteristics ofInfection & chemotherapy · 2023Article
- Characteristics ofAccess microbiology · 2023Article
- Phenotypical Detection of β-Lactamases in a Multidrug-Resistant and Extensively Drug-ResistantMicrobiology insights · 2023Article
- A Curious Case of Chryseobacterium indologenes Culture in a Young Adult Kidney Transplant Patient.Cureus · 2023Article
- Indwelling central venous catheter infection withAccess microbiology · 2023Article
- Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report.Cureus · 2022Article
- Whole genome sequencing of the multidrug-resistantFrontiers in medicine · 2022Article
- Article
- Metagenomic analysis of MWWTP effluent treated via solar photo-Fenton at neutral pH: Effects upon microbial community, priority pathogens, and antibiotic resistance genes.The Science of the total environment · 2021Article
- Article
- Oral Abscess Caused byAntibiotics (Basel, Switzerland) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chryseobacterium indologenes are aerobic, Gram negative, nonfermentative rods that are intrinsically multi-drug resistant. Reported infections include bacteremia, pneumonia, meningitis, myositis, keratitis, and indwelling devices. We present the clinical course of a 52-year-old African male with a medical history of end stage renal disease (ESRD) in hemodialysis with multiple episodes of central line-associated bloodstream infections (CLABSI) presenting with symptoms of chills, malaise, and localized erythema on insertion site of permacath. Blood cultures obtained from catheter showed C. indologenes. Successful response was obtained with piperacillin/tazobactam based on sensitivity and removal of indwelling catheter. Given the increase in the number of cases reported in the literature, guidelines for the management of this pathogen should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.